WFN Press Releases

2024 World Brain Day Dedicated to Brain Health and Prevention

7 May 2024

The World Federation of Neurology (WFN) is pleased to announce Brain Health and Prevention as the theme for the 2024 World Brain Day (WBD 2024), taking place on Monday, July 22. The goal is to raise critical awareness to prevent brain disease in all corners of the globe.

WFN Elections 2024: Call for nominations

1 Mar 2024

The World Federation of Neurology is pleased to announce the upcoming election of one trustee. position. We encourage all member societies, to suggest suitable candidates. The WFN has presently 124 member societies, representing World Neurology with a focus on education and global activities.

WCN 2023 Tournament of the Minds Winners

10 Nov 2023

Thirteen teams competed in the initial knock-out phase, including several departmental teams from India and teams from Sri Lanka, Japan, Kenya, Mexico, UK, Sudan and Hong Kong.

WFN 2023 Election Results

2 Nov 2023

The results of the WFN 2023 Elections for Treasurer and one elected trustee were announced during the recent Council of Delegates Meeting, as well as the location for the WCN 2027.

President of African Academy of Neurology Calls for Urgent, Unified Action to Address Lack of Trained Neurologists Throughout

19 Oct 2023

Africa currently experiences some of the most extreme shortages of neurologists and health care funding and some of the highest rates of disability due to neurological disorders in the world. Dr. Augustina Charway-Felli, president of the African Academy of Neurology, recently proposed a plan for addressing these disparities by emphasizing regional training to increase the number of neurologists throughout Africa and prioritizing education for primary care providers and non-specialists.

New Research on Drastically Reducing Long-Term Disability After a Stroke

19 Oct 2023

Stroke is a leading cause of disability worldwide, and over 15 million people suffer a stroke each year—yet 80% of strokes are preventable. There are treatments that can successfully treat a stroke in progress and reduce long-term disability, but they must be given soon after the start of a stroke. Because global health care systems are drastically under-resourced, these treatments are often not available to the people who need them.

Kathy Oliver Champions Global Action for Patient Organizations at the 26th World Congress of Neurology

18 Oct 2023

There is a growing call to embrace patient engagement in the world of health care, and Kathy Oliver, chair of the International Brain Tumour Alliance (IBTA), is one of many patient advocates at the vanguard of this movement around the world. Patient organizations like IBTA are increasingly at the forefront of patient engagement across various health care domains, including in the design of clinical trials, drug development, health care policy, pricing and reimbursement decisions, and regulatory issues.

Dr. Huda Zoghbi Reveals New Research Into the Mechanisms Driving Rett Syndrome at the 2023 World Congress of Neurology

18 Oct 2023

Huda Zoghbi, MD, professor of molecular and human genetics, Baylor College of Medicine, has made a groundbreaking discovery in the field of neurology. Her research shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood disorder that primarily affects females and is diagnosed in around 1 in 10,000 girls born each year. 

New Results From HEALEY ALS Platform Trial Show Promise for Treating ALS

17 Oct 2023

One of the central challenges of Amyotrophic Lateral Sclerosis ALS research is finding ways to slow the progression of the relentlessly degenerative brain disease. Recently, based on results of the HEALEY ALS Platform Trial, two experimental medications plan to move to phase 3 clinical trials. This means the drugs will now be tested on a larger sample population to confirm promising early results that showed they can slow the progression of ALS. Phase 3 trials are the last step before drugs are submitted for FDA approval. 

Neurologist Anthony Lang Presents Groundbreaking News on Parkinson’s Disease at World Congress of Neurology 2023

17 Oct 2023

During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson's Disease Research, University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinson’s disease. This new approach will help researchers investigate biological aspects of the disease that may be detectable many years before symptoms begin to show.

Hidden Neurological Consequences of Historic Pandemics

16 Oct 2023

Among U.S. adults who have had COVID-19, a staggering 28% report having experienced long COVID complications, and the CDC estimates that long COVID currently impacts 6% of the population. Despite the prevalence of long COVID, researchers still don’t understand the full scope of COVID-19’s impact on the brain. 

Number of People Living With Brain Disease Expected to Double by 2050

16 Oct 2023

Neurological disorders are currently the second highest cause of death and the leading cause of disability worldwide. A groundbreaking new Global Burden of Disease (GBD) study shows that the number of people living with brain disease is expected to double by 2050. 

World Health Organization Presents Global Action Plan for Neurological Disorders at World Congress of Neurology

15 Oct 2023

The World Health Organization (WHO) revealed its new Intersectoral Global Action Plan (IGAP), a critical blueprint for combating neurological conditions that calls for urgent action from governments and health care organizations around the world. IGAP outlines goals to help governments and national health care organizations direct research and investment in areas with the greatest possible impact on global health.

Breaking Boundaries in Diabetes Care: Dr. Eva L. Feldman's Vision for a Healthier World

15 Oct 2023

Type 2 diabetes has reached epidemic proportions, and diabetic peripheral neuropathy (DPN), a major diabetes complication, is now a leading cause of global disability. Eva L. Feldman, MD, PhD, James W. Albers Distinguished University Professor and Russell N. DeJong Professor of Neurology at Michigan Medicine, shined a light on the growing global burden of DPN and revealed evidence that diet and lifestyle modifications can improve diabetic neuropathy at the 26th World Congress of Neurology

Prestigious World Congress of Neurology Returns In-Person to Convene World-Class Researchers in Montreal

11 Oct 2023

The World Federation of Neurology (WFN) and the Canadian Neurological Society (CNS) will host the XXVI World Congress of Neurology (WCN) in Montreal, Canada, from October 15 to 19, 2023. WCN is a major, biennial conference where world-class neurologists and researchers gather to share the latest innovative research in the broad field of neurology. This year’s WCN marks the first in-person conference since the COVID-19 pandemic, with thousands of attendees from around the world convening to learn from one another’s research, exchange ideas and drive the field of neurology forward.

2023 Brain Health and Disability Webinar: Leave No One Behind

19 Jul 2023

This year marks the 10th Anniversary of World Brain Day and WFN is partnering with the World Federation for Neurorehabilitation (WFNR). Registration is now open for the free 2023 World Brain Day webinar.

WFN Elections 2023: Election Candidates

27 May 2023

The Nominating Committee of the World Federation of Neurology now recommends to the membership candidates for WFN Treasurer and Elected Trustee.

World Brain Day 2023: Putting A Spotlight On Brain Health And Disability

11 Apr 2023

The World Federation of Neurology (WFN) is pleased to announce Brain Health and Disability as the theme for its 10th Annual World Brain Day (WBD) on Saturday, July 22. This year’s theme Brain Health and Disability will inspire a global initiative to close the gaps in disability awareness and reduce health care barriers that exist for individuals with neurological disabilities. When it comes to brain health, may we leave no one behind.

WFN joins WHO Support Group for the "Global Road Map to Defeat Meningitis by 2030"

30 Dec 2022

On 28 December, 2023, WFN President Prof Dr Wolfgang Grisold was honoured to be invited to serve as a member of World Health Organisation's (WHO) Support Group for the "Global Road Map to Defeat Meningitis by 2030" on behalf of World Federation of Neurology (WFN). 

Two New Co-opted Trustee Appointments

14 Nov 2022

The World Federation of Neurology is pleased to announce the appointments of Prof Riadh Gouider and Prof Marco Tulio Medina as co-opted Trustees for a one-year term covering the period from October 2022 to the next Council of Delegates meeting in October 2023.

1 3 4 5